ChiCTR2100048548 版本V1.0 版本创建时间2022/02/22 20:45:18 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100048548 

最近更新日期:

Date of Last Refreshed on:

2021-07-10 21:53:23 

注册时间:

Date of Registration:

2021-07-10 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

请于伦理委员会批准后才开始征募参试者,并与我们联系上传伦理批件。 新生儿脑发育及其影响因素的超声脑功能成像研究

Public title:

Study of neonatal brain development with functional ultrasound

注册题目简写:

English Acronym:

研究课题的正式科学名称:

Scientific title:

N/A

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

周发亮 

研究负责人:

刘黎黎 

Applicant:

Faliang Zhou 

Study leader:

Lili Liu 

申请注册联系人电话:

Applicant telephone:

16601117784

研究负责人电话:

Study leader's telephone:

13810536759

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zflhfing@163.com

研究负责人电子邮件:

Study leader's E-mail:

liulili0205@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京大学第一医院第一住院部

研究负责人通讯地址:

北京大学第一医院第一住院部

Applicant address:

No.8 Xishiku Street, Xicheng District, Beijing

Study leader's address:

No.8 Xishiku Street, Xicheng District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京大学第一医院

Applicant's institution:

Peking University First Hospital

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

否/No

Approved by ethic committee:

No

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

北京大学第一医院儿科

Primary sponsor:

Peking University First Hospital pediatric department

研究实施负责(组长)单位地址:

北京市西城区西什库大街8号

Primary sponsor's address:

No.8 Xishiku Street, Xicheng District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京大学第一医院

具体地址:

西城区西什库大街8号

Institution
hospital:

Peking University First Hospital

Address:

8 Xishiku street, Xicheng District

经费或物资来源:

Source(s) of funding:

N/A

Target disease:

neonatal brain development

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

(1)正常新生儿脑发育的超声功能成像特点 (2)脑损伤新生儿的超声功能成像特点 (3)超声脑功能成像技术与床旁脑电图等其他脑功能检查方法的一致性 (4)评估超声脑功能成像技术在神经系统发育预后预测中的价值  

Objectives of Study:

(1) Functional ultrasound imaging characteristics of normal neonatal brain development (2) Functional ultrasound imaging characteristics of neonates with brain injury (3) Consistency between ultrasound functional brain imaging and other functional examination methods such as bedside EEG (4) Evaluation of the value of functional ultrasound imaging in the prognosis of neurological development

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

根据病史、临床症状、体征、颅脑影像学(常规颅脑超声、MRI)、脑电图等综合诊断,包括:新生儿惊厥,3-4度颅内出血,脑梗死,脑积水(出血后、感染后、代谢性等),中-重度新生儿缺氧缺血性脑病,围产期脑卒中,胆红素脑病,新生儿细菌性脑膜炎,代谢性脑病、脑发育畸形等。

Inclusion criteria

Diagnosis based on history, clinical symptoms, signs, cranial imaging (cranial ultrasound, MRI), EEG, etc., including: neonatal convulsions, III-IV degree intracranial hemorrhage, cerebral infarction, hydrocephalus (post-hemorrhagic, post-infectious, metabolic, etc.), moderate-to-severe neonatal hypoxic-ischemic encephalopathy, perinatal stroke, bilirubin encephalopathy, neonatal bacterial meningitis, metabolic encephalopathy, developmental malformations of the brain, etc.

排除标准:

1)在数据采集过程中,被试哭闹难以安抚,使采集不能完成者;
2)被试新生儿存在囟门处头皮破损、感染,不能完成数据采集者;
3)家属拒绝参与研究。

Exclusion criteria:

(1) Those cry and are difficult to be soothed during the data collection process, making this process impossible to complete.
2) Those who had scalp breakage or infection at fontanelle, making it impossible to complete data collection.
(3) The family members refused to participate in the study.

研究实施时间:

Study execute time:

From 2021-07-10 00:00:00 To 2022-07-10 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-07-10 00:00:00 To 2025-07-10 00:00:00  

干预措施:

Interventions:

组别:

Case series

样本量:

40

Group:

Case series

Sample size:

干预措施:

干预措施代码:

Intervention:

No

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China 

Province:

Beijing 

City:

 

单位(医院):

北京大学第一医院 

单位级别:

三级甲等 

Institution
hospital:

Peking University First Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

脑血容量变化值

指标类型:

主要指标

Outcome:

Changes in cerebral blood volume

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

符合纳入标准均可

Randomization Procedure (please state who generates the random number sequence and by what method):

anyone acccording with the inclusion criteria

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

N/A

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

基于个体化的病例记录以及检查结果

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

case records and results for every patients

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-07-10 21:53:23